Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Drug Reviewers And Legal Staff Among Those Called Back to US FDA, But Why?
Feb 26 2025
•
By
Sarah Karlin-Smith
The FDA is recalling more staff just one week after instituting layoffs.
(Shutterstock)
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Leadership
More from HBW Insight